J. M. López Vega

Adjuvant docetaxel for high-risk, node-negative breast cancer.

A. Ruíz, A. Lluch, J. Zaluski, 2010, The New England journal of medicine.

Analysis of the changes induced by bevacizumab using a high temporal resolution DCE-MRI as prognostic factors for response to further neoadjuvant chemotherapy

A. Plazaola, A. Elizalde, J. Etxano, 2015, Acta radiologica.

Carboplatin: an active drug in metastatic breast cancer.

E. Adrover, E. Díaz-Rubio, M. Martín, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of carboplatin in advanced breast cancer: preliminary results.

E. Díaz-Rubio, A. Casado, J. M. López Vega, 1991, Seminars in oncology.

Intravenous and Oral Magnesium Supplementations in the Prophylaxis of Cisplatin‐Induced Hypomagnesemia

E. Díaz-Rubio, A. Casado, J. Sastre, 1992, American journal of clinical oncology.